Lexaria Bioscience Corp Financial Flexibility Index
Lexaria Bioscience Corp financial flexibility index. Lexaria Bioscience Corp (LEXX) has a Financial Flexibility Index of -3.68x as of May 2026. Free cash flow of $-1.61 Million (operating CF $-1.64 Million minus capex $26.25K) represents -4% of total liabilities ($437.09K). See how much free cash does Lexaria Bioscience Corp generate to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Lexaria Bioscience Corp (2005–2025)
Financial flexibility index of Lexaria Bioscience Corp from 2005 to 2025. Historical Financial Flexibility Index trend for Lexaria Bioscience Corp across 21 annual periods. Check Lexaria Bioscience Corp earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Lexaria Bioscience Corp Financial Flexibility Index by Year (2005–2025)
Lexaria Bioscience Corp financial flexibility index by year from 2005 to 2025. Year-by-year free cash flow to debt coverage for Lexaria Bioscience Corp. For the full cash flow conversion analysis, see Lexaria Bioscience Corp cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -6.63x | $-10.43 Million | $-10.45 Million | $1.57 Million | ▼ -63.0% |
| 2024 | -4.07x | $-4.92 Million | $-4.96 Million | $1.21 Million | ▲ +71.2% |
| 2023 | -14.14x | $-5.71 Million | $-5.88 Million | $403.91K | ▲ +41.0% |
| 2022 | -23.98x | $-4.83 Million | $-4.88 Million | $201.44K | ▼ -24.6% |
| 2021 | -19.24x | $-3.91 Million | $-3.99 Million | $203.26K | ▼ -157.5% |
| 2020 | -7.47x | $-2.59 Million | $-2.62 Million | $345.98K | ▲ +38.4% |
| 2019 | -12.12x | $-2.24 Million | $-3.01 Million | $184.51K | ▲ +78.3% |
| 2018 | -55.74x | $-2.43 Million | $-2.52 Million | $43.64K | ▼ -235.1% |
| 2017 | -16.64x | $-1.54 Million | $-1.55 Million | $92.35K | ▼ -1143.3% |
| 2016 | -1.34x | $-640.75K | $-660.86K | $478.88K | ▲ +95.0% |
| 2015 | -26.56x | $-1.46 Million | $-1.50 Million | $55.12K | ▼ -9590.5% |
| 2014 | 0.28x | $412.61K | $321.00K | $1.47 Million | ▲ +0.0% |
| 2013 | 0.28x | $412.61K | $321.00K | $1.47 Million | ▼ -1.1% |
| 2012 | 0.28x | $412.61K | $321.00K | $1.46 Million | ▲ +15.8% |
| 2011 | 0.24x | $410.07K | $135.94K | $1.68 Million | ▼ -67.6% |
| 2010 | 0.75x | $1.11 Million | $109.84K | $1.48 Million | ▲ +2127.4% |
| 2009 | -0.04x | $-45.09K | $-330.34K | $1.21 Million | ▼ -115.6% |
| 2008 | 0.24x | $187.42K | $-36.40K | $788.18K | ▼ -84.4% |
| 2007 | 1.52x | $611.47K | $29.04K | $400.98K | ▲ +64.3% |
| 2006 | 0.93x | $1.87 Million | $-218.56K | $2.01 Million | ▼ -99.2% |
| 2005 | 123.18x | $1.38 Million | $-153.38K | $11.18K | — |